ADAPTIMMUNE THERAPEUTICS PLC: accounts_payable
| Value | {"amount": 8128000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | ADAPTIMMUNE THERAPEUTICS PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/87ddf89c-7d06-4f93-9f6a-2660d0983702
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-002537 · Open the official SEC filing →Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001621227/accounts-payable/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/87ddf89c-7d06-4f93-9f6a-2660d0983702
History
- no predecessors — first report